Edition:
United States

Xvivo Perfusion AB (XVIVO.ST)

XVIVO.ST on Stockholm Stock Exchange

109.00SEK
11:13am EDT
Change (% chg)

-1.80kr (-1.62%)
Prev Close
110.80kr
Open
111.40kr
Day's High
112.00kr
Day's Low
108.00kr
Volume
13,305
Avg. Vol
36,402
52-wk High
112.00kr
52-wk Low
82.00kr

Chart for

About

Xvivo Perfusion AB is a Sweden-based medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. The Company operates in two segments: Durable goods and Non-Durable goods. The Durable goods segment comprises sale and rental income from XVIVO... (more)

Overall

Beta: 0.62
Market Cap(Mil.): kr2,901.91
Shares Outstanding(Mil.): 26.19
Dividend: --
Yield (%): --

Financials

  XVIVO.ST Industry Sector
P/E (TTM): 288.19 39.03 32.90
EPS (TTM): 0.38 -- --
ROI: 2.44 14.34 12.74
ROE: 2.45 17.21 14.64

BRIEF-XVIVO Perfusion Has Submitted Premarket Approval Application For XPS With STEEN Solution To FDA

* XVIVO PERFUSION HAS SUBMITTED PREMARKET APPROVAL APPLICATION FOR XPS WITH STEEN SOLUTION TO FDA Source text for Eikon: Further company coverage:

May 11 2018

BRIEF-Xvivo Perfusion Q1 Adjusted. EBITDA Sek 7.2 Million

* Q1 ADJUSTED. EBITDA SEK 7.2 MILLION VERSUS SEK 5.0 MILLION YEAR AGO

Apr 26 2018

BRIEF-Xvivo Perfusion AB Net Sales Of Non-Durable Goods In Q4 Amounted To Sek 39.4 (34.6) Million

* NET SALES OF NON-DURABLE GOODS IN Q4 AMOUNTED TO SEK 39.4 (34.6) MILLION

Feb 09 2018

Earnings vs. Estimates